Prazosina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Prazosina" in Italian language version.

refsWebsite

Global rank Italian rank

12nih.gov

4^th place

9^th place

12doi.org

2^nd place

7^th place

2s3-us-west-2.amazonaws.com

low place

3,547^th place

1fda.gov

447^th place

644^th place

1drugbank.com

low place

4,124^th place

1utoronto.ca

1,601^st place

2,796^th place

1uky.edu

3,273^rd place

low place

doi.org

dx.doi.org

Simon Kung, Zelde Espinel e Maria I. Lapid, Treatment of nightmares with prazosin: a systematic review, in Mayo Clinic Proceedings, vol. 87, n. 9, 2012-09, pp. 890-900, DOI:10.1016/j.mayocp.2012.05.015. URL consultato il 14 luglio 2023.
Steven M. Hudson, Travis E. Whiteside e Raymond A. Lorenz, Prazosin for the treatment of nightmares related to posttraumatic stress disorder: a review of the literature, in The primary care companion for CNS disorders, vol. 14, n. 2, 2012, pp. PCC.11r01222, DOI:10.4088/PCC.11r01222. URL consultato il 14 luglio 2023.
Maju Mathew Koola, Sajoy P. Varghese e Jan A. Fawcett, High-dose prazosin for the treatment of post-traumatic stress disorder, in Therapeutic Advances in Psychopharmacology, vol. 4, n. 1, 2014-02, pp. 43-47, DOI:10.1177/2045125313500982. URL consultato il 14 luglio 2023.
W. F. Stanaszek, D. Kellerman e R. N. Brogden, Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure, in Drugs, vol. 25, n. 4, 1983-04, pp. 339-384, DOI:10.2165/00003495-198325040-00002. URL consultato il 14 luglio 2023.
P. Jaillon, Clinical pharmacokinetics of prazosin, in Clinical Pharmacokinetics, vol. 5, n. 4, 1980, pp. 365-376, DOI:10.2165/00003088-198005040-00004. URL consultato il 14 luglio 2023.
Jamil Mayet e Alun Hughes, Cardiac and vascular pathophysiology in hypertension, in Heart (British Cardiac Society), vol. 89, n. 9, 2003-09, pp. 1104-1109, DOI:10.1136/heart.89.9.1104. URL consultato il 14 luglio 2023.
Giacomo Ronzoni, Alberto Del Arco e Francisco Mora, Enhanced noradrenergic activity in the amygdala contributes to hyperarousal in an animal model of PTSD, in Psychoneuroendocrinology, vol. 70, 2016-08, pp. 1-9, DOI:10.1016/j.psyneuen.2016.04.018. URL consultato il 14 luglio 2023.
J. L. Reid, Alpha-adrenergic receptors and blood pressure control, in The American Journal of Cardiology, vol. 57, n. 9, 28 marzo 1986, pp. 6E–12E, DOI:10.1016/0002-9149(86)90716-2. URL consultato il 14 luglio 2023.
F. Lefèvre-Borg, O. Mathias e I. Cavero, Role of the sympathetic nervous system in blood pressure maintenance and in the antihypertensive effects of calcium antagonists in spontaneously hypertensive rats, in Hypertension (Dallas, Tex.: 1979), vol. 11, n. 4, 1988-04, pp. 360-370, DOI:10.1161/01.hyp.11.4.360. URL consultato il 14 luglio 2023.
A. Grahnén, P. Seideman e B. Lindström, Prazosin kinetics in hypertension, in Clinical Pharmacology and Therapeutics, vol. 30, n. 4, 1981-10, pp. 439-446, DOI:10.1038/clpt.1981.186. URL consultato il 14 luglio 2023.
F. Brunner e W. E. Müller, Prazosin binding to human alpha 1-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the 'single drug binding site' of orosomucoid, in The Journal of Pharmacy and Pharmacology, vol. 37, n. 5, 1985-05, pp. 305-309, DOI:10.1111/j.2042-7158.1985.tb05071.x. URL consultato il 14 luglio 2023.
John C. L. Erve, Sarvesh C. Vashishtha e William DeMaio, Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry, in Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 35, n. 6, 2007-06, pp. 908-916, DOI:10.1124/dmd.106.013219. URL consultato il 14 luglio 2023.

drugbank.com

go.drugbank.com

Prazosin, su go.drugbank.com. URL consultato il 14 luglio 2023.

fda.gov

accessdata.fda.gov

FDA approval information, Prazosin, su accessdata.fda.gov.

nih.gov

pubmed.ncbi.nlm.nih.gov

Simon Kung, Zelde Espinel e Maria I. Lapid, Treatment of nightmares with prazosin: a systematic review, in Mayo Clinic Proceedings, vol. 87, n. 9, 2012-09, pp. 890-900, DOI:10.1016/j.mayocp.2012.05.015. URL consultato il 14 luglio 2023.
Steven M. Hudson, Travis E. Whiteside e Raymond A. Lorenz, Prazosin for the treatment of nightmares related to posttraumatic stress disorder: a review of the literature, in The primary care companion for CNS disorders, vol. 14, n. 2, 2012, pp. PCC.11r01222, DOI:10.4088/PCC.11r01222. URL consultato il 14 luglio 2023.
Maju Mathew Koola, Sajoy P. Varghese e Jan A. Fawcett, High-dose prazosin for the treatment of post-traumatic stress disorder, in Therapeutic Advances in Psychopharmacology, vol. 4, n. 1, 2014-02, pp. 43-47, DOI:10.1177/2045125313500982. URL consultato il 14 luglio 2023.
W. F. Stanaszek, D. Kellerman e R. N. Brogden, Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure, in Drugs, vol. 25, n. 4, 1983-04, pp. 339-384, DOI:10.2165/00003495-198325040-00002. URL consultato il 14 luglio 2023.
P. Jaillon, Clinical pharmacokinetics of prazosin, in Clinical Pharmacokinetics, vol. 5, n. 4, 1980, pp. 365-376, DOI:10.2165/00003088-198005040-00004. URL consultato il 14 luglio 2023.
Jamil Mayet e Alun Hughes, Cardiac and vascular pathophysiology in hypertension, in Heart (British Cardiac Society), vol. 89, n. 9, 2003-09, pp. 1104-1109, DOI:10.1136/heart.89.9.1104. URL consultato il 14 luglio 2023.
Giacomo Ronzoni, Alberto Del Arco e Francisco Mora, Enhanced noradrenergic activity in the amygdala contributes to hyperarousal in an animal model of PTSD, in Psychoneuroendocrinology, vol. 70, 2016-08, pp. 1-9, DOI:10.1016/j.psyneuen.2016.04.018. URL consultato il 14 luglio 2023.
J. L. Reid, Alpha-adrenergic receptors and blood pressure control, in The American Journal of Cardiology, vol. 57, n. 9, 28 marzo 1986, pp. 6E–12E, DOI:10.1016/0002-9149(86)90716-2. URL consultato il 14 luglio 2023.
F. Lefèvre-Borg, O. Mathias e I. Cavero, Role of the sympathetic nervous system in blood pressure maintenance and in the antihypertensive effects of calcium antagonists in spontaneously hypertensive rats, in Hypertension (Dallas, Tex.: 1979), vol. 11, n. 4, 1988-04, pp. 360-370, DOI:10.1161/01.hyp.11.4.360. URL consultato il 14 luglio 2023.
A. Grahnén, P. Seideman e B. Lindström, Prazosin kinetics in hypertension, in Clinical Pharmacology and Therapeutics, vol. 30, n. 4, 1981-10, pp. 439-446, DOI:10.1038/clpt.1981.186. URL consultato il 14 luglio 2023.
F. Brunner e W. E. Müller, Prazosin binding to human alpha 1-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the 'single drug binding site' of orosomucoid, in The Journal of Pharmacy and Pharmacology, vol. 37, n. 5, 1985-05, pp. 305-309, DOI:10.1111/j.2042-7158.1985.tb05071.x. URL consultato il 14 luglio 2023.
John C. L. Erve, Sarvesh C. Vashishtha e William DeMaio, Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry, in Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 35, n. 6, 2007-06, pp. 908-916, DOI:10.1124/dmd.106.013219. URL consultato il 14 luglio 2023.

s3-us-west-2.amazonaws.com

FDA Label - Minipress® Capsules (prazosin hydrochloride) For Oral Use, su s3-us-west-2.amazonaws.com.
SAFETY DATA SHEET - Prazosin (hydrochloride) 01/02/2019 Revision, su s3-us-west-2.amazonaws.com.

uky.edu

The pharmacology of adrenergic receptors ^{[collegamento interrotto]}, su uky.edu.

utoronto.ca

pie.med.utoronto.ca

Cardiac anesthesiology, University of Toronto, su pie.med.utoronto.ca.